Venati S, Uversky V
Int J Mol Sci. 2024; 25(15).
PMID: 39125972
PMC: 11313516.
DOI: 10.3390/ijms25158399.
LaCroix M, Mirbaha H, Shang P, Zandee S, Foong C, Prat A
Acta Neuropathol Commun. 2022; 10(1):146.
PMID: 36221144
PMC: 9552360.
DOI: 10.1186/s40478-022-01444-2.
Azouz M, Feuillie C, Lafleur M, Molinari M, Lecomte S
Nanoscale Adv. 2022; 3(14):4244-4253.
PMID: 36132846
PMC: 9417262.
DOI: 10.1039/d1na00055a.
Xie J, Zhang Y, Li S, Wei H, Yu H, Zhou Q
Clin Transl Med. 2022; 12(8):e1003.
PMID: 35917404
PMC: 9345400.
DOI: 10.1002/ctm2.1003.
Du F, Yu Q, Kanaan N, Yan S
Hum Mol Genet. 2022; 31(15):2498-2507.
PMID: 35165721
PMC: 9396941.
DOI: 10.1093/hmg/ddab363.
Three-repeat and four-repeat tau isoforms form different oligomers.
Shahpasand-Kroner H, Portillo J, Lantz C, Seidler P, Sarafian N, Loo J
Protein Sci. 2021; 31(3):613-627.
PMID: 34902187
PMC: 8862439.
DOI: 10.1002/pro.4257.
Andrographolide Attenuates Gut-Brain-Axis Associated Pathology in Gulf War Illness by Modulating Bacteriome-Virome Associated Inflammation and Microglia-Neuron Proinflammatory Crosstalk.
Saha P, Skidmore P, Holland L, Mondal A, Bose D, Seth R
Brain Sci. 2021; 11(7).
PMID: 34356139
PMC: 8304847.
DOI: 10.3390/brainsci11070905.
Early detection of Alzheimer's disease using creatine chemical exchange saturation transfer magnetic resonance imaging.
Chen L, van Zijl P, Wei Z, Lu H, Duan W, Wong P
Neuroimage. 2021; 236:118071.
PMID: 33878375
PMC: 8321389.
DOI: 10.1016/j.neuroimage.2021.118071.
STAT3 ameliorates cognitive deficits via regulation of NMDAR expression in an Alzheimer's disease animal model.
Wan H, Hong X, Zhao Z, Li T, Zhang B, Liu Q
Theranostics. 2021; 11(11):5511-5524.
PMID: 33859760
PMC: 8039956.
DOI: 10.7150/thno.56541.
STAT3 ameliorates cognitive deficits by positively regulating the expression of NMDARs in a mouse model of FTDP-17.
Hong X, Wan H, Li T, Zhang B, Li X, Wang X
Signal Transduct Target Ther. 2020; 5(1):295.
PMID: 33361763
PMC: 7762755.
DOI: 10.1038/s41392-020-00290-9.
Constant Levels of Tau Phosphorylation in the Brain of htau Mice.
Neddens J, Daurer M, Loeffler T, Alzola Aldamizetxebarria S, Flunkert S, Hutter-Paier B
Front Mol Neurosci. 2020; 13:136.
PMID: 32982685
PMC: 7485327.
DOI: 10.3389/fnmol.2020.00136.
Humanization of the entire murine gene provides a murine model of pathological human tau propagation.
Saito T, Mihira N, Matsuba Y, Sasaguri H, Hashimoto S, Narasimhan S
J Biol Chem. 2019; 294(34):12754-12765.
PMID: 31273083
PMC: 6709628.
DOI: 10.1074/jbc.RA119.009487.
Using proteomics to identify ubiquitin ligase-substrate pairs: how novel methods may unveil therapeutic targets for neurodegenerative diseases.
Rayner S, Morsch M, Molloy M, Shi B, Chung R, Lee A
Cell Mol Life Sci. 2019; 76(13):2499-2510.
PMID: 30919022
PMC: 11105231.
DOI: 10.1007/s00018-019-03082-9.
Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies.
Fuster-Matanzo A, Hernandez F, Avila J
Int J Mol Sci. 2018; 19(3).
PMID: 29495325
PMC: 5877506.
DOI: 10.3390/ijms19030645.
Tau prions from Alzheimer's disease and chronic traumatic encephalopathy patients propagate in cultured cells.
Woerman A, Aoyagi A, Patel S, Kazmi S, Lobach I, Grinberg L
Proc Natl Acad Sci U S A. 2016; 113(50):E8187-E8196.
PMID: 27911827
PMC: 5167200.
DOI: 10.1073/pnas.1616344113.
Gene Therapy Models of Alzheimer's Disease and Other Dementias.
Combs B, Kneynsberg A, Kanaan N
Methods Mol Biol. 2015; 1382:339-66.
PMID: 26611599
PMC: 4734109.
DOI: 10.1007/978-1-4939-3271-9_25.
Nonhuman amyloid oligomer epitope reduces Alzheimer's-like neuropathology in 3xTg-AD transgenic mice.
Rasool S, Martinez-Coria H, Milton S, Glabe C
Mol Neurobiol. 2013; 48(3):931-40.
PMID: 23771815
DOI: 10.1007/s12035-013-8478-7.
Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice.
Rasool S, Martinez-Coria H, Wu J, LaFerla F, Glabe C
J Neurochem. 2013; 126(4):473-82.
PMID: 23672786
PMC: 4105004.
DOI: 10.1111/jnc.12305.
Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin.
Ubhi K, Rockenstein E, Doppler E, Mante M, Adame A, Patrick C
Acta Neuropathol. 2009; 117(6):699-712.
PMID: 19252918
PMC: 3049872.
DOI: 10.1007/s00401-009-0505-4.
Interactions of amyloidogenic proteins.
Giasson B, Lee V, Trojanowski J
Neuromolecular Med. 2003; 4(1-2):49-58.
PMID: 14528052
DOI: 10.1385/NMM:4:1-2:49.
